Growing Hospital Acquired Infections (HAIs) or nosocomial infections are expected to drive the antibacterial glass market in the coming years. Traditional techniques of decontamination such as washing hands at periodic intervals are insufficient in a healthcare setting. Antibacterial glass provides an effective solution against bacteria such as MRSA (Methicillin-
Europe is expected to remain the market leader over the forecast period due to high degree of acceptance of antibacterial glass coupled with the presence of key players such as AGC Glass Europe in the region. The European market is expected to grow at a CAGR of 7.0% from 2012 to 2018, significantly higher than the global average of 6.3%. In terms of application, hospitals held the highest market share, and were valued at USD 53.3 million in 2012. Household and other applications are expected to witness slow growth in the coming years.
Silver was the largest market in terms of active ingredients. AGC Glass Europe uses silver to infuse glass and make it antibacterial nature, while other companies use silver and other ingredients such as zinc and copper for coating the glass.
The market is highly consolidated, with companies such as AGC Glass Europe and Nippon Sheet Glass involved in manufacturing of antibacterial glass through infusion and coating respectively. Majority of industry participants have distribution networks and are not involved in the production process. Key players include AGC Glass Europe, Saint-Gobain, Nippon Sheet Glass, BÜFA Glas GmbH & Co. KG, etc.
Browse the report With Full TOC at http://www.transparencymarketresearch.com/
The report segments the global antibacterial glass market as:
Antibacterial Glass Market: Active Ingredients Analysis
Others (Copper, zinc, titanium, etc.)
Antibacterial Glass Market: Application Analysis
Food and beverage
Others (Hotels, decorative glass, etc.)
Antibacterial Glass Market: Regional Analysis
Rest of the World (RoW)